Related Experiment Video
Updated: Jun 9, 2026

Visualization of DNA Repair Proteins Interaction by Immunofluorescence
Published on: June 26, 2020
Redox-dependent Brca1 transcriptional regulation by an NADH-sensor CtBP1
1Department of Dermatology, University of Colorado, Denver, Aurora, CO 80045, USA.
Abstract:
C-terminal binding protein 1 (CtBP1) is a transcriptional co-repressor and metabolic sensory protein, which often represses tumor suppressor genes. Hence, we sought to determine if CtBP1 affects expression of the tumor suppressor Brca1 in head and neck tissue, as downregulation of Brca1 begins at the early stages of head and neck squamous cell carcinomas (HNSCCs). We found that CtBP1 represses Brca1 transcription by binding to the E2F4 site of the Brca1 promoter. Additionally, the recruitment of CtBP1 to the Brca1 promoter is redox-dependent, that is, increased at high NADH levels in hypoxic conditions. Further, immunostaining using a human HNSCC tissue array revealed that nuclear CtBP1 staining began to accumulate in hyperplasic lesions and HNSCCs, this staining correlated with Brca1 downregulation in these lesions. Pharmacological disruption of CtBP1 binding to Brca1 promoter by the antioxidant Tempol, which reduces NADH levels, relieved CtBP1-mediated repression of Brca1, leading to increased DNA repair in HNSCC cells. As tumor cells are generally hypoxic with increased NADH levels, the dynamic control of Brca1 by a 'metabolic switch' found in this study not only provides an important link between tumor metabolism and tumor suppressor expression but also suggests a potential chemo preventative or therapeutic strategy for HNSCC by blocking NADH-dependent CtBP1 activity at early stages of HNSCC carcinogenesis.
Insights
C-terminal binding protein 1 (CtBP1) represses the tumor suppressor Brca1 in head and neck cancers. Blocking CtBP1 activity with antioxidants may offer a new therapeutic strategy for head and neck squamous cell carcinomas (HNSCCs).
Area of Science:
- Molecular Biology
- Cancer Research
- Metabolic Regulation
Background:
- C-terminal binding protein 1 (CtBP1) is a transcriptional co-repressor that often represses tumor suppressor genes.
- Brca1 downregulation is an early event in head and neck squamous cell carcinomas (HNSCCs).
Purpose of the Study:
- To investigate if CtBP1 affects Brca1 expression in head and neck tissue.
- To elucidate the mechanism of CtBP1-mediated Brca1 repression and its potential as a therapeutic target.
Main Methods:
- Analysis of CtBP1 binding to the Brca1 promoter using molecular techniques.
- Assessment of CtBP1 recruitment dependency on NADH levels and hypoxia.
- Immunostaining of human HNSCC tissue arrays.
- Pharmacological inhibition of CtBP1 activity using Tempol.
Main Results:
- CtBP1 represses Brca1 transcription by binding to the E2F4 site on the Brca1 promoter.
- CtBP1 recruitment to the Brca1 promoter is redox-dependent, increasing with high NADH levels under hypoxia.
- Nuclear CtBP1 accumulation correlates with Brca1 downregulation in HNSCC lesions.
- Tempol treatment relieved CtBP1-mediated repression, increasing Brca1 expression and DNA repair in HNSCC cells.
Conclusions:
- CtBP1 acts as a metabolic switch, linking tumor metabolism to tumor suppressor expression in HNSCC.
- Blocking NADH-dependent CtBP1 activity presents a potential chemo-preventative or therapeutic strategy for HNSCC.
- Findings provide insights into the early stages of HNSCC carcinogenesis and suggest novel therapeutic avenues.
Related Concept Videos
Co-activators and Co-repressors
Master Transcription Regulators
Transcriptional Regulation: Riboswitches
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Transcription Attenuation in Prokaryotes
There are several different mechanisms used to attenuate transcription. In ribosome mediated...
Regulation of Nuclear Protein Sorting

